Molecular Docking Studies of Schiff Bases with Azetidinone Against Dihydrofolate Reductase Enzyme as Potential Anti-cancer Agents. (2024). Asian Journal of Pharmaceutics (AJP), 18(02). https://doi.org/10.22377/ajp.v18i02.5480